BUZZ-Australia's Memphasys gains 40% on orders from Qatari customer
Reuters
Feb 02
BUZZ-Australia's Memphasys gains 40% on orders from Qatari customer
** Shares of Memphasys MEM.AX rise 40% to A$0.007, their highest level since Jan 15** Co says that Hamad Medical Corporation, Qatar's largest IVF institution, commences commercial ordering of Felix cartridges for clinical use** Felix system is co's patented bio separation technology that isolates the most viable sperm cells for human assisted reproduction** Shares dropped 28.6% in January
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.